{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:46:12Z","timestamp":1786992372042,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1993"],"award-info":[{"award-number":["2023NSFSC1993"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3605900"],"award-info":[{"award-number":["2023YFC3605900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3605901"],"award-info":[{"award-number":["2023YFC3605901"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jgo.2026.102894","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T07:51:04Z","timestamp":1769673064000},"page":"102894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk factors for venous thromboembolism in older patients with malignant solid tumors: A systematic review"],"prefix":"10.1016","volume":"17","author":[{"given":"Xue","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgo.2026.102894_bb0005","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMra1712502","article-title":"Cancer survivorship","volume":"379","author":"Shapiro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgo.2026.102894_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.31664","article-title":"Global cancer incidence in older adults, 2012 and 2035: a population-based study","volume":"144","author":"Pilleron","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jgo.2026.102894_bb0015","first-page":"409","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jgo.2026.102894_bb0020","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2026.102894_bb0025","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3390\/diagnostics12122954","article-title":"Venous thromboembolism in cancer patients undergoing chemotherapy: a systematic review and meta-analysis","volume":"12","author":"Sun","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.jgo.2026.102894_bb0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jval.2017.09.015","article-title":"What impact does venous thromboembolism and bleeding have on cancer patients\u2019 quality of life?","volume":"21","author":"Lloyd","year":"2018","journal-title":"Value Health"},{"key":"10.1016\/j.jgo.2026.102894_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: burden, mechanisms, and management","volume":"117","author":"Ay","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jgo.2026.102894_bb0040","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1186\/s12885-020-06930-1","article-title":"Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study","volume":"20","author":"Howlett","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgo.2026.102894_bb0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.6004\/jnccn.2024.0046","article-title":"Cancer-associated venous thromboembolic disease, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Streiff","year":"2024","journal-title":"J Natl Compr Can Netw"},{"key":"10.1016\/j.jgo.2026.102894_bb0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jgo.2026.102894_bb0055","doi-asserted-by":"crossref","first-page":"e583","DOI":"10.1016\/S2352-3026(20)30211-8","article-title":"Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis","volume":"7","author":"Klemen","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jgo.2026.102894_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CEOR.S39964","article-title":"Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States","volume":"5","author":"Khorana","year":"2013","journal-title":"ClinicoEcon Outcomes Res"},{"key":"10.1016\/j.jgo.2026.102894_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2016.02.030","article-title":"Direct medical costs attributable to cancer-associated venous thromboembolism: a population-based longitudinal study","volume":"129","author":"Cohoon","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jgo.2026.102894_bb0070","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2026.102894_bb0075","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"International Initiative on Thrombosis and Cancer (ITAC) advisory panel, 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2026.102894_bb0080","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12254-020-00657-2","article-title":"Prevalence of comorbidities in elderly cancer patients","volume":"14","author":"Wenkstetten-Holub","year":"2020","journal-title":"Memo"},{"key":"10.1016\/j.jgo.2026.102894_bb0085","doi-asserted-by":"crossref","first-page":"4902","DOI":"10.1182\/blood-2007-10-116327","article-title":"Development and validation of a predictive model for chemotherapy-associated thrombosis","volume":"111","author":"Khorana","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2026.102894_bb0090","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jgo.2026.102894_bb0095","unstructured":"G.A. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp, [n.d.] (accessed 21 December 2025)."},{"key":"10.1016\/j.jgo.2026.102894_bb0100","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.eururo.2012.01.045","article-title":"Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism","volume":"61","author":"Hu","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.jgo.2026.102894_bb0105","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1002\/cncr.35424","article-title":"Association between epidermal growth factor receptor\u2013tyrosine kinase inhibitors and venous thromboembolism among older patients with advanced non\u2013small cell lung cancer","volume":"130","author":"Byun","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2026.102894_bb0110","first-page":"695","article-title":"Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer","volume":"27","author":"Du","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jgo.2026.102894_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/bju.14685","article-title":"Chemotherapy regimen is associated with venous thromboembolism risk in patients with urothelial tract cancer","volume":"124","author":"Ramos","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.jgo.2026.102894_bb0120","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000012842","article-title":"Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer: a case-control study","volume":"97","author":"Lin","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.jgo.2026.102894_bb0125","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/AOG.0000000000000866","article-title":"Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer","volume":"125","author":"Rauh-Hain","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jgo.2026.102894_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2407-13-209","article-title":"Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data","volume":"13","author":"Connelly-Frost","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgo.2026.102894_bb0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13569-015-0033-z","article-title":"Older soft tissue sarcoma patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data","volume":"5","author":"Shantakumar","year":"2015","journal-title":"Clin Sarcoma Res"},{"key":"10.1016\/j.jgo.2026.102894_bb0140","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/182521","article-title":"Predictors of venous thromboembolism in patients with advanced common solid cancers","author":"Hall","year":"2009","journal-title":"J Cancer Epidemiol"},{"key":"10.1016\/j.jgo.2026.102894_bb0145","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41598-020-58345-4","article-title":"Prognosis and risk factors in older patients with lung cancer and pulmonary embolism: a propensity score matching analysis","volume":"10","author":"Junjun","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jgo.2026.102894_bb0150","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/annonc\/mdq777","article-title":"Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer","volume":"22","author":"Chavez-MacGregor","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2026.102894_bb0155","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/cam4.4581","article-title":"Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: a SEER-Medicare analysis","volume":"11","author":"Ades","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.jgo.2026.102894_bb0160","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/MBC.0000000000001043","article-title":"Risk of venous thromboembolism and endocrine therapy in older women with breast cancer in the United States","volume":"32","author":"Faiz","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jgo.2026.102894_bb0165","first-page":"e21","article-title":"Risks of venous thromboembolism, stroke, heart disease, and myelodysplastic syndrome associated with hematopoietic growth factors in a large population-based cohort of patients with colorectal cancer","volume":"14","author":"Du","year":"2015","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jgo.2026.102894_bb0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.thromres.2018.10.002","article-title":"Venous thrombosis and breast cancer in older women: racial differences in risk factors and mortality","volume":"171","author":"Faiz","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jgo.2026.102894_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.794310","article-title":"Association of gonadotropin-releasing hormone therapies with venous thromboembolic events in patients with prostate cancer: a national cohort study","volume":"9","author":"Hong","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jgo.2026.102894_bb0180","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2010.03986.x","article-title":"Venous thrombosis in the elderly: incidence, risk factors and risk groups","volume":"8","author":"Engbers","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jgo.2026.102894_bb0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10654-014-9902-7","article-title":"The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Troms\u00f8 study","volume":"29","author":"Blix","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.jgo.2026.102894_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1160\/TH15-08-0686","article-title":"Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study","volume":"117","author":"Cohen","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jgo.2026.102894_bb0195","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jgo.2026.102894_bb0200","first-page":"8547","article-title":"Anticoagulation and bleeding in the cancer patient","volume":"30","author":"Escobar","year":"2022","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jgo.2026.102894_bb0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11739-012-0784-y","article-title":"A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score","volume":"7","author":"Verso","year":"2012","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jgo.2026.102894_bb0210","first-page":"2084","article-title":"Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?","volume":"138","author":"Pelzer","year":"2013","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jgo.2026.102894_bb0215","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1634\/theoncologist.2016-0414","article-title":"A predictive score for thrombosis associated with breast, colorectal, lung, or ovarian cancer: the prospective COMPASS-cancer-associated thrombosis study","volume":"22","author":"Gerotziafas","year":"2017","journal-title":"Oncologist"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406826000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406826000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:35:11Z","timestamp":1774056911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406826000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1879406826000482"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2026.102894","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for venous thromboembolism in older patients with malignant solid tumors: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2026.102894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102894"}}